The latest announcement is out from Alcidion Group Limited ( (AU:ALC) ).
Alcidion Group Limited has announced the appointment of Professor Andrew Way AM as a Non-Executive Director, succeeding Victoria Weekes who will step down mid-year. Professor Way brings extensive experience in healthcare management and IT, aligning with Alcidion’s mission to support the healthcare industry. His appointment is part of Alcidion’s strategic plan to scale the company and expand its customer base, leveraging his expertise in quality patient care and healthcare systems.
More about Alcidion Group Limited
Alcidion Group Limited is a company focused on transforming healthcare through proactive, smart, and intuitive technology solutions aimed at improving the efficiency and quality of patient care globally. Their flagship product, Miya Precision, aggregates information to centralised dashboards, supports interoperability, and delivers Clinical Decision Support at the point of care. Since its ASX listing in 2011, Alcidion has expanded its operations across the UK, Australia, and New Zealand, serving over 400 hospitals and 87 healthcare organisations.
YTD Price Performance: 20.0%
Average Trading Volume: 1,944,237
Technical Sentiment Signal: Buy
Current Market Cap: A$96.69M
See more data about ALC stock on TipRanks’ Stock Analysis page.